Michael Greig serves as the Executive Director of MRMS Sales and Global Pharma/BioPharma LSMS at Bruker since April 2023. Prior to this role, Michael held the position of Director for Pharma/Biopharma Americas at Bruker Daltonics from 2018 to May 2023, where responsibilities included leading the Business Unit for Life Sciences Mass Spectrometry in the Americas. Michael’s extensive experience in the pharmaceutical sector includes a significant tenure at Pfizer as Director of US Pharma/BioPharma Business and Associate Research Fellow in Protein Dynamics from July 1997 to September 2017. Earlier in the career, Michael was Lab Manager for Mass Spectrometry at Ionis Pharmaceuticals, Inc., and worked as a Polymer Chemist at Revlon. Michael holds a Bachelor of Science degree in Chemistry from the University of Delaware.
This person is not in any teams
This person is not in any offices